Sreoshi Chatterjee 452 posts 0 comments

Illumina asserted the appointment of Dr. Phil Febbo who is a Leading physician scientist, as Chief Medical Officer (CMO), starting March 26, 2018. In his new role, Dr. Febbo will be…
Read More...

The American Society for Radiation Oncology declared a new clinical guideline for the usage of whole breast radiation therapy for breast Cancer augmenting the population of patients…
Read More...

Connexient which is the healthcare leader in enterprise digital wayfinding , mapping and indoor navigation services set to roll out enhanced software version, MediNav Navigator 3.0.…
Read More...

Merriimack Pharmaceuticals which is a clinical-stage oncology company focused on biomarker-defined cancers asserted that it is augmenting enrollment in the ongoing randomized Phase 2…
Read More...

BioVentrix announced successful treatment of the first patient at the Cardiovascular Institute of the South in the ALIVE pivotal clinical trial. The trial is designed to demonstrate the…
Read More...

Check-Cap which is a clinical-stage medical diagnostics company engaged in the development of C-Scan which is an ingestible capsule for preparation-free, colorectal cancer screening,…
Read More...

Cadent Therapeutics which is a precision neuroscience company developing novel medicines to restore movement and cognitive function in patients with neurological and psychiatric disease…
Read More...

Cantex Pharmaceuticals which is a clinical stage  bio-pharmaceutical company developing proprietary pharmaceuticals that enhance the treatment of cancers and other fatal disorders…
Read More...

Autonomic Technologies asserted that the College of the French National Authority for Health issued a optimistic opinion on Forfait Innovation package for the Pulsante SPG…
Read More...

MYR Pharma GmbH asserted the completion of MYR 202 Clinical Trial which is a Phase 2b study investigating Myrcludex B in chronic hepatitis Delta patients which is a more acute form of…
Read More...